• Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

  • Mar 14 2024
  • Duración: 9 m
  • Podcast

Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected? Por arte de portada

Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this podcast, Chiara De Biase and Jean Marco highlight three key reasons for Charles Dotter's failure to spread his method widely in the USA. Firstly, his position as a radiologist, not a vascular surgeon; secondly, his aggressive presentation of the technique, coupled with limited patient data; and lastly, his unconventional approach to developing tools and the lack of clear objectives.

    Stay tuned to discover how Dotter's method made its way to Europe in the next episode.


    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles